Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Trinity Biotech Plc (TRIB)
NASDAQ:TRIB
Trinity Biotech (TRIB) Stock Price & Analysis
218 Followers
TRIB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.80 - $1.50
Previous Close$1.04
Volume41.48K
Average Volume (3M)40.95K
Market Cap
$40.01M
Enterprise Value$77.35M
Total Cash (Recent Filing)$6.58M
Total Debt (Recent Filing)$44.30M
Price to Earnings (P/E)-0.8
Beta0.80
Next Earnings
Jul 20, 2023EPS Estimate
-$0.06Last Dividend Ex-Date
Jun 05, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-1.28
Shares Outstanding38,210,000
10 Day Avg. Volume24,848
30 Day Avg. Volume40,950
Standard Deviation0.23
R-Squared0.11
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.98
Price to Sales (P/S)0.49
Price to Cash Flow (P/CF)4.00
P/FCF Ratio2.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.36
Enterprise Value/Gross Profit3.51
Enterprise Value/Ebitda-11.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Trinity Biotech News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TRIB FAQ
What was Trinity Biotech Plc’s price range in the past 12 months?
Trinity Biotech Plc lowest stock price was $0.80 and its highest was $1.50 in the past 12 months.
What is Trinity Biotech Plc’s market cap?
Currently, no data Available
When is Trinity Biotech Plc’s upcoming earnings report date?
Trinity Biotech Plc’s upcoming earnings report date is Jul 20, 2023 which is in 40 days.
How were Trinity Biotech Plc’s earnings last quarter?
Currently, no data Available
Is Trinity Biotech Plc overvalued?
According to Wall Street analysts Trinity Biotech Plc’s price is currently Overvalued.
Does Trinity Biotech Plc pay dividends?
Trinity Biotech Plc pays a Annually dividend of $0.22 which represents an annual dividend yield of N/A. See more information on Trinity Biotech Plc dividends here
What is Trinity Biotech Plc’s EPS estimate?
Trinity Biotech Plc’s EPS estimate is -$0.06.
How many shares outstanding does Trinity Biotech Plc have?
Trinity Biotech Plc has 38,207,570 shares outstanding.
What happened to Trinity Biotech Plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Trinity Biotech Plc?
Among the largest hedge funds holding Trinity Biotech Plc’s share is Stonehill Capital Management Llc. It holds Trinity Biotech Plc’s shares valued at 1M.
---
Trinity Biotech Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 84.7K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.63%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-22.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Trinity Biotech Plc
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---